Bill Type
Long Title
AN ACT STRENGTHENING THE REGULATORY SYSTEM IN THE COUNTRY TO COMBAT COUNTERFEIT PHARMACEUTICAL PRODUCTS, DECLARING THE MANUFACTURE, IMPORTATION, DISTRIBUTION, SALE OR OFFER FOR SALE, OR POSSESSION OF COUNTERFEIT PHARMACEUTICAL PRODUCTS AS AN OFFENSE INVOLVING ECONOMIC SABOTAGE, PROVIDING PENALTIES FOR VIOLATIONS THEREOF, REPEALING FOR THE PURPOSE REPUBLIC ACT NO. 8203, OTHERWISE KNOWN AS THE "SPECIAL LAW ON COUNTERFEIT DRUGS"
Date filed
September 23, 2019
Scope

Legislative History

House Bill/Resolution NO. HB04779
FULL TITLE : AN ACT STRENGTHENING THE REGULATORY SYSTEM IN THE COUNTRY TO COMBAT COUNTERFEIT PHARMACEUTICAL PRODUCTS, DECLARING THE MANUFACTURE, IMPORTATION, DISTRIBUTION, SALE OR OFFER FOR SALE, OR POSSESSION OF COUNTERFEIT PHARMACEUTICAL PRODUCTS AS AN OFFENSE INVOLVING ECONOMIC SABOTAGE, PROVIDING PENALTIES FOR VIOLATIONS THEREOF, REPEALING FOR THE PURPOSE REPUBLIC ACT NO. 8203, OTHERWISE KNOWN AS THE "SPECIAL LAW ON COUNTERFEIT DRUGS"
PRINCIPAL AUTHOR/S : TAN, ANGELINA "HELEN" D.L. M.D.
DATE FILED : 2019-09-23
SIGNIFICANCE: NATIONAL
CO-AUTHORS (Journal Entries) :
1. Alonte (000 2021-02-15)
ACTIONS TAKEN BY THE COMMITTEE ON RULES
REFERRAL TO THE COMMITTEE ON HEALTH ON 2019-09-25
Disclaimer

Note: Legislative history and other information accessed from Congress Legis. Information as of April 20, 2022.